Literature DB >> 21537091

Hybrid & El Tor variant biotypes of Vibrio cholerae O1 in Thailand.

M Na-Ubol1, P Srimanote, M Chongsa-Nguan, N Indrawattana, N Sookrung, P Tapchaisri, S Yamazaki, L Bodhidatta, B Eampokalap, H Kurazono, H Hayashi, G B Nair, Y Takeda, W Chaicumpa.   

Abstract

BACKGROUND &
OBJECTIVES: El Tor Vibrio cholerae O1 carrying ctxB C trait, so-called El Tor variant that causes more severe symptoms than the prototype El Tor strain, first detected in Bangladesh was later shown to have emerged in India in 1992. Subsequently, similar V. cholerae strains were isolated in other countries in Asia and Africa. Thus, it was of interest to investigate the characteristics of V. cholerae O1 strains isolated chronologically (from 1986 to 2009) in Thailand.
METHODS: A total of 330 V. cholerae O1 Thailand strains from hospitalized patients with cholera isolated during 1986 to 2009 were subjected to conventional biotyping i.e., susceptibility to polymyxin B, chicken erythrocyte agglutination (CCA) and Voges-Proskauer (VP) test. The presence of ctxA, ctxB, zot, ace, toxR, tcpA C , tcpA E, hlyA C and hlyA E were examined by PCR. Mismatch amplification mutation assay (MAMA) - and conventional- PCRs were used for differentiating ctxB and rstR alleles.
RESULTS: All 330 strains carried the El Tor virulence gene signature. Among these, 266 strains were typical El Tor (resistant to 50 units of polymyxin B and positive for CCA and VP test) while 64 had mixed classical and El Tor phenotypes (hybrid biotype). Combined MAMA-PCR and the conventional biotyping methods revealed that 36 strains of 1986-1992 were either typical El Tor, hybrid, El Tor variant or unclassified biotype. The hybrid strains were present during 1986-2004. El Tor variant strains were found in 1992, the same year when the typical El Tor strains disappeared. All 294 strains of 1993-2009 carried ctxBC ; 237 were El Tor variant and 57 were hybrid. INTERPRETATION &
CONCLUSIONS: In Thailand, hybrid V. cholerae O1 (mixed biotypes), was found since 1986. Circulating strains, however, are predominantly El Tor variant (El Tor biotype with ctxB C).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537091      PMCID: PMC3103171     

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


Vibrio cholerae, the causative agent of severe watery diarrhoeal disease cholera, comprises 206 serogroups (O1-O206) based on antigenic diversity of their outer membrane lipopolysaccharides12. Strains of the O1 serogroup are divided into two biotypes i.e., classical and El Tor, according to their phenotypic differences. The classical strains are sensitive to 50 units of polymyxin B and Mukerjee’s type IV bacteriophage while the El Tor strains are generally dually resistant with the exception of some strains isolated in southern Bangladesh34. The El Tor strains are more adapted and resilient in environment, and cause higher infection to case ratio and more asymptomatic carriers than the classical counterpart5. Clinical manifestations of cholera caused by classical V. cholerae are more severe and prolonged than those caused by the El Tor67. This is attributable to the subtle difference of cholera toxin (CT) encoded by ctxAB genes of V. cholerae. Each of the V. cholerae O1 biotype can be divided into three serotypes i.e., Ogawa, Inaba, and Hikojima. Since 1817, the world has experienced seven cholera pandemics caused by V. cholerae O1. Strains of classical biotype were considered as the causative agents for the first six pandemics while the 7th cholera pandemic which started in 1961 from Sulawesi Island, Indonesia, was caused by El Tor V. cholerae O1. Since then, the El Tor V. cholerae had replaced the classical biotype as the sole cause of cholera epidemics until 1982 when there was a re-emergence of the classical V. cholerae isolated from patients during an epidemic in Bangladesh8–10. Both biotypes co-existed in Bangladesh until the classical vibrios became extinct in 1993. Until 1991, only toxigenic V. cholerae O1 strains caused cholera epidemic and pandemics. In 1992, a large cholera outbreak was reported from southern India and subsequently spread rapidly to neighbouring countries in several countries in Asia but did not spread to any other continent. The epidemic organism was non-O1 V. cholerae which could not be allocated into any of the pre-existing non-O1 serogroups. Subsequently, the organism was designated as serogroup O139 synonym Bengal in recognition of the place of origin11–13. New V. cholerae O1 variants carrying mixed classical and El Tor phenotypes were first isolated from hospitalized patients with severe watery diarrhoea in Matlab, Bangladesh, in 20023. These isolates could not be allocated into the classical or El Tor biotype using conventional biotyping tests. Genotypically, these were found to carry the El Tor genome backbone including El Tor specific gene clusters: VSP-I and -II and RTX, indicating that these belonged to El Tor lineage. These isolates carried different combinations of alleles of tcpA and CTX prophage repressor gene (rstR)4. Their classical biotype characteristic was due to the presence of the classical CTX prophage and the deduced amino acids of the nucleotide sequence coding for cholera toxin B subunit belonged to classical biotype. Similar strains were isolated in Mozambique in 200414. Subsequently, V. cholerae O1 El Tor variants have been reported from several Asian countries including China, Japan, Hong Kong, Sri Lanka, and Vietnam and Africa (Zambia)15. In a retrospective study of V. cholerae strains isolated in Kolkata, India, during a 17 year period (1989-2005), using mis-match amplification mutation assay (MAMA)-PCR for determining ctxB alleles, it was revealed that the El Tor strains carrying ctxB allele of the classical biotype (ctxB) have emerged since 1991 and co-existed with the prototype El Tor strains until 1995 when these completely replaced the typical El Tor biotype. Arbitrarily, the V. cholerae O1 strains carrying mixed phenotypes of classical and El Tor biotypes [polymyxin B (50 units) susceptibility and positive for chicken erythrocyte agglutination (CCA) and Voges-Proskauer (VP) test] are designated hybrid biotype where as the V. cholerae O1 with typical El Tor phenotypes (resistant to 50 units of polymyxin B, and positive for CCA and VP test) but carrying ctxB are designated El Tor variant16. This nomenclature has been followed in this study. The 7th pandemic cholera arrived in Thailand in 1963, when the El Tor strains completely replaced the classical vibrios and established endemicity17. The O139 Bengal was first isolated from hospitalized patient with severe watery diarrhoea in Thailand in 199318. The O139 serogroup completely disappeared from Thailand since 199617. Because it is known that classical V. cholerae strains with ctxB inflicted more severe symptoms than the typical El Tor infection616 and because there had been a resurgence of cases of severe watery diarrhoea that required hospitalization during 1999-2002, it was of interest to make an insight into both phenotypic and genotypic characteristics of V. cholerae O1 isolated from cholera patients in different years in Thailand.

Material & Methods

Bacterial strains: A total of 330 V. cholerae O1 strains (248 Ogawa, 82 Inaba) isolated from hospitalized patients with cholera in various regions of Thailand from 1986 to 2009 (Table I) were investigated. Nineteen V. cholerae O1 strains collected from Australia, Bangladesh, India, Peru, Romania and Thailand in different years were used as reference strains419 (Table II). Among them, 16 strains were obtained from the collection of the Laboratory Science Division, the International Centre for Diarrhoeal Disease Research of Bangladesh, Dhaka, Bangladesh; two strains (G27875 and SC11) were provided by Dr T. Ramamurthy, the National Centre of Cholera and Enteric Diseases, Kolkata, India; and one strain (295/33) was from the Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. All strains were subjected to conventional biotyping methods (susceptibility to 50 units of polymyxin B, CCA and VP test)20 using strains 569B and N16961 as the classical and El Tor reference strains, respectively.
Table I

V. cholerae O1 strains isolated from Thailand during 1986-2009

Year of isolation (n)Strain no.SerotypePhenotype
Genotype
Biotype (see also Table IV)Number of strain(s)/total number of strain(s) of the year
PBCCAVPctxBrstR
1986 (5)1-2InabaR++EEEl Tor2/5
3InabaR++EE+CEl Tor1/5
4InabaS-+EEHybrid group 11/5
5InabaR++E+CEUnclassified group 11/5
1987 (1)6InabaR++EEEl Tor1/1
1989 (2)7InabaR-+E+CE+CHybrid group 21/2
8InabaS++EE+CHybrid group 31/2
1990 (13)9-12InabaR++EE+CEl Tor4/13
13-16OgawaR++EEEl Tor4/13
17-18InabaR++E+CE+CUnclassified group 22/13
19-21OgawaR++E+CEUnclassified group 13/13
1991 (4)22OgawaR++EEEl Tor1/4
23-25OgawaR++E+CEUnclassified group 13/4
1992 (11)26InabaR++EE+CEl Tor1/11
27InabaS++EEHybrid group 41/11
28OgawaR++EEEl Tor1/11
29OgawaR++E+CEUnclassified group 11/11
30-33OgawaR++CE+CEl Tor variant4/11
34-36OgawaR-+CE+CHybrid group 53/11
1993 (9)37-38InabaR++CE+CEl Tor variant2/9
39-43OgawaR++CE+CEl Tor variant5/9
44OgawaR+-CE+CHybrid group 61/9
45OgawaR++CCEl Tor variant1/9
1994 (7)46InabaR+-CE+CHybrid group 61/7
47-51OgawaR++CE+CEl Tor variant5/7
52OgawaS++CE+CHybrid group 71/7
1995 (11)53-62OgawaR++CE+CEl Tor variant10/11
63OgawaR+-CE+CHybrid group 61/11
1996 (3)64-65OgawaR++CE+CEl Tor variant2/3
66OgawaS++CE+CHybrid group 71/3
1997 (3)67OgawaR++CE+CEl Tor variant1/3
68-69OgawaR++CCEl Tor variant2/3
1998 (2)70-71OgawaR++CCEl Tor variant2/2
1999 (179)72-78InabaR++CCEl Tor variant7/179
79-83OgawaR++CE+CEl Tor variant5/179
84-85OgawaR+-CE+CHybrid group 62/179
86-115OgawaR+-CCHybrid group 830/179
116-247OgawaR++CCEl Tor variant132/179
248OgawaR-+CCHybrid group 91/179
249OgawaR--CCHybrid group 101/179
250OgawaS++CCHybrid group 111/179
2000 (21)251-270OgawaR++CCEl Tor variant20/21
271OgawaR+-CCHybrid group 81/21
2001 (27)272-294InabaR++CCEl Tor variant23/27
295-298InabaR+-CCHybrid group 84/27
2002 (13)299-306InabaR++CCEl Tor variant8/13
307InabaR+-CCHybrid group 81/13
308-310InabaS++CCHybrid group 113/13
311OgawaR++CCEl Tor variant1/13
2003 (8)312-315InabaR++CCEl Tor variant4/8
316InabaR+-CCHybrid group 81/8
317InabaS++CCHybrid group 111/8
318InabaS+-CCHybrid group 121/8
319InabaS-+CCHybrid group 131/8
2004 (9)320-324InabaR++CCEl Tor variant5/9
325-327InabaR+-CCHybrid group 83/9
328InabaS+-CCHybrid group 121/9
2009 (2)329-330OgawaR++CCEl Tor variant2/2

n, total number of strain(s) of the indicated year; PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination; VP, Voges-Proskauer test; MAMA, mismatch amplification mutation assay; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor

Table II

V. cholerae O1 reference strains isolated from various countries

No.Name of isolate (n=19)Year of isolationCountry of originSerotypePhenotype
Genotype
Biotype
Originally identified biotype
PBCCAVPctxBrstR
1569B1948IndiaInabaS--CCClassicalClassical
2GP711971IndiaOgawaR++CEEl Tor variantEl Tor
3N169611975BangladeshInabaR++EEEl TorEl Tor
42463-781978AustraliaInabaR--CCHybridEl Tor
5GP1561979AustraliaOgawaR+-CEHybridEl Tor
62164-881988United statesInabaR++CCEl Tor variantEl Tor
7295/331990ThailandOgawaR-+E+CEHybridEl Tor
8C67061991PeruInabaR++E+CEHybridEl Tor
9C77541991RomaniaOgawaR+-CE+CHybridEl Tor
10MJ14851994BangladeshInabaR-+CCHybridEl Tor
11B332004MozambiqueOgawaR+-CCHybridEl Tor
12AR15493UnknownBangladeshInabaR++CEEl Tor variantEl Tor
13AR15425UnknownBangladeshInabaR++CEEl Tor variantEl Tor
14G27875UnknownIndia (NICED)OgawaR++CEEl Tor variantEl Tor
15SC11UnknownIndia (NICED)OgawaR++CEEl Tor variantEl Tor
16GP12UnknownIndiaOgawaR+-CEHybridEl Tor
17AS230UnknownIndiaOgawaR++CEEl Tor variantEl Tor
18AS231UnknownIndiaOgawaR++CEEl Tor variantEl Tor
19AS233UnknownIndiaOgawaR-+CEHybridEl Tor

PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination;, VP, Voges-Proskauer test; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor

V. cholerae O1 strains isolated from Thailand during 1986-2009 n, total number of strain(s) of the indicated year; PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination; VP, Voges-Proskauer test; MAMA, mismatch amplification mutation assay; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor V. cholerae O1 reference strains isolated from various countries PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination;, VP, Voges-Proskauer test; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor Conventional- and MAMA-PCRs: All V. cholerae strains were examined for the presence of ctxA, ctxB, zot, ace, toxR, tcpA and hlyA by conventional PCR using strains AR15493 and AR15425 from Bangladesh as positive controls for zot, ace, toxR, and hlyA genes and strain C6706 as positive control for ctxAB and tcpA19. Conventional biotyping methods and a combination of MAMA- and conventional- PCRs were used for classifying the strains into prototype El Tor, hybrid, or El Tor variant biotypes, based on their ctxB and rstR genes21–23. Strains MJ1485 from Bangladesh and B33 from Mozambique served as hybrid biotype reference strains while G27875 and SC11 from NICED, India, were El Tor variant reference strains. Primer sequences used in PCRs are shown in Table III19. Amplification mixture (25 μl) for ctxB-MAMA-PCR and rstR-PCR composed of 1 μl bacterial genomic DNA template, 2.5 μl 10× PCR buffer, 2 μl each of 2.5 mM deoxynucleotide triphosphate (Fermentas, Vilnius, Lithuania), 2 μl of 25 mM MgCl2, 2 μl of 10 μM of individual forward and reverse primers (Bio Basic Inc., Toronto, Canada), 0.5 units Taq DNA polymerase (Fermentas) and sterile ultra pure distilled water. Amplification of other genes was essentially the same as described previously19. The PCR products were analyzed by using 1.5 per cent agarose (Seakem LE, BMA, Glendate, CA, USA) gel electrophoresis and ethidium bromide staining (Sigma Chemical Co., USA). A Gel Doc 2000 (Bio-Rad, CA, USA) was used for DNA band documentation.
Table III

PCR primers for the study of V. cholerae O1 genes

Gene (s)Primer sequenceSize of PCR amplicon (bp)PCR condition
Reference
Initial denaturationDenaturationAnnealingExtensionFinal extensionNo. of cycles
Simple PCR
rstREForward: GCACCATGATTTAAGATGCTC501 (El Tor)94°C, 5 min94°C, 60 s58°C, 60 s72°C, 90 s72°C, 7 min3022
Reverse: TCGAGTTGTAATTCATCAAGAGTG
rstRCForward: CTTCTCATCAGCAAAGCCTCCATC474 (Classical)94°C, 5 min94°C, 60 s64°C, 60 s72°C, 90 s72°C, 7 min3022
Reverse: TCGAGTTGTAATTCATCAAGAGTG
MAMA-PCR
ctxBForward: ACTATCTTCAGCATATGCACATGG96°C, 2 min96°C, 10 s55°C, 10 s72°C, 30 s72°C, 2 min2521
Reverse for El Tor: CTGGTACTTCTACTTGAAACA
Reverse for classical: CTGGTACTTCTACTTGAAACG
MAMA-PCR, mismatch amplification mutation assay-PCR
PCR primers for the study of V. cholerae O1 genes

Results & Discussion

All of the 330 V. cholerae O1 Thai clinical strains collected over 24 years (1986-2009) were found to carry ctxA, ctxB, zot, ace, toxR, tcpA and hlyA which verified genetically their toxin producing capacity and epidemic potential. Two hundred and sixty six strains were prototype El Tor (resistant to the polymyxin B, and positive for CCA and VP test) and the remaining 64 strains were not biotypable (Table I). Identification of rstR by conventional PCR showed that the 36 strains of 1986-1992 carried either the El Tor rstR (rstR) or combination of the El Tor and classical rstR (rstR) (Table I). MAMA-PCR for ctxB of these isolates revealed that 18 (50%) carried ctxB. Only 15 of these 18 strains had prototype El Tor phenotype (resistant to 50 units of polymyxin B, and positive for CCA and VP test) indicating that they were typical El Tor biotype. The other 3 strains, although carrying ctxB, appeared to be hybrid biotype as they possessed mixed phenotypes (Table I and IV). There were 11 strains of 1986-1992 (31%) that carried ctxB. Among these only one strain had mixed classical and El Tor phenotypes implying that this was hybrid biotype. The remaining 10 with ctxB, however, could not be assigned into any of the redefined biotype scheme16 although these showed conventional El Tor phenotype (Tables I and IV. The remaining seven (19%) of the 1986-1992 (all were isolated in 1992) strains carried ctxB ; four of these had conventional El Tor phenotypes implying that these were El Tor variant while the other three had mixed phenotypes, and were hybrid (Table I). These data indicate the presence of hybrid biotype of V. cholerae O1 in Thailand since 1986 or even before and these co-existed with the typical El Tor strains. The V. cholerae O1 Thailand strains that carried ctxB., typical El Tor strains, were found for the last time in 1992 in this V. cholerae O1 collection which was the same year when the strains of El Tor variant biotype (strains 30-33) carrying ctxB emerged in the country (Table I). It is noteworthy that in 1992 the epidemic V. cholerae O139 strains emerged in Southern India11. The Fig. shows MAMA-PCR results of representative strains of V. cholerae chronologically isolated in Thailand i.e., ctxB (Fig. A) and ctxB (Fig. B).
Table IV

Biotypes of the 330 V. cholerae Thailand clinical strains

BiotypeGenotype
Phenotype
ctxBrstRPBCCAVP
ClassicalCCS--
El TorEER++
El TorEE+CR++
Hybrid group 1EES-+
Hybrid group 2E+CE+CR-+
Hybrid group 3EE+CS++
Hybrid group 4EES++
Hybrid group 5CE+CR-+
Hybrid group 6CE+CR+-
Hybrid group 7CE+CS++
Hybrid group 8CCR+-
Hybrid group 9CCR-+
Hybrid group 10CCR--
Hybrid group 11CCS++
Hybrid group 12CCS+-
Hybrid group 13CCS-+
El Tor variantCCR++
El Tor variantCE+CR++
Unclassified group 1E+CER++
Unclassified group 2E+CE+CR++

PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination; VP, Voges-Proskauer test; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor

Fig.

Results of MAMA-PCR for amplification of ctxB (A) and ctxBE (B) from representative V. cholerae strains isolated in Thailand during 1986-2009. Lanes 2-6, 1986 strains; lane 7, 1987 strains; lanes 8-9, 1989 strains; lanes 10-22, 1990 strains; lanes 23-26, 1991 strains; lanes 27-36, 1992 strains and lanes 37-56, 1993-2009 strains. Lane M, 100 bp DNA marker. Lane 1 in (A), positive control of ctxB (569B); lane 1 in (B), positive control of ctxB (N16961).

Biotypes of the 330 V. cholerae Thailand clinical strains PB, susceptibility to 50 units of polymyxin B; CCA, chicken red blood cell agglutination; VP, Voges-Proskauer test; R, resistant; S, sensitive; +, positive; -, negative; C, classical; E, El Tor Results of MAMA-PCR for amplification of ctxB (A) and ctxBE (B) from representative V. cholerae strains isolated in Thailand during 1986-2009. Lanes 2-6, 1986 strains; lane 7, 1987 strains; lanes 8-9, 1989 strains; lanes 10-22, 1990 strains; lanes 23-26, 1991 strains; lanes 27-36, 1992 strains and lanes 37-56, 1993-2009 strains. Lane M, 100 bp DNA marker. Lane 1 in (A), positive control of ctxB (569B); lane 1 in (B), positive control of ctxB (N16961). The V. cholerae O1 Thailand strains of 1993-2009 (294) were all found to carry ctxBC and either rstR or rstR . Majority of these strains (237 strains), however, were El Tor variants as their phenotypes were typical El Tor. The minority (57 strains) belonged to hybrid biotype because these had mixed phenotypes of classical and El Tor (Table I). The 1986-2009 Thailand strains with hybrid biotype could be arbitrarily classified into 13 different hybrid groups, 1-13 (Table IV). During 1986-1992, the biotypes of the 36 V. cholerae O1 Thailand strains were 15 prototype El Tor, 7 hybrid (groups 1-5), 4 El Tor variant, and 10 unclassified (unclassified groups 1 and 2) (Tables I and IV). The 294 strains of 1993-2009 belonged to hybrid groups 6-13 (57 strains) and El Tor variants (237 strains) (Tables I and IV). The V. cholerae O1 of hybrid biotype was isolated from patients in India in 1991 when typical V. cholerae classical and El Tor biotypes co-existed suggesting the horizontal CTX prophage exchange between strains of the two principal biotypes in order for the infecting strains to be more adapted to the host hostile intestinal environment15 which conformed to the more severe cholera symptoms in the afflicted hosts in the recent years32224. It is noteworthy, however, that the classical V. cholerae O1 disappeared from Thailand since 196325 when the 7th cholera pandemic caused by typical El Tor strains first hit the Kingdom’s population. There has been no report on the period of co-existing classical and El Tor strains during 1986-2009 within Thailand. Our finding that the V. cholerae hybrid biotype could be detected among strains of 1986 suggested that there might be a re-emergence of the classical V. cholerae before or during 1986 or there might be other confounding molecular mechanism(s) in the shifting of the characteristics of V. cholerae bacteria in Thailand. The speculations warrant detail investigation. In 1992, the epidemic O139 strains emerged in India concurrent with the finding of El Tor variant in Thailand for the first time in this series of strain collection (Table I). Between 1992 and 1993, the V. cholerae O1 strains carrying ctxB predominated in Kolkata, India15 and Thailand (this study). Thus, there seemed to be incomprehensible event of genetic evolution of the V. cholerae yielding strains of mixed traits/phenotypes of the two authentic biotypes during this period. After 1994, isolates of V. cholerae O1 in Kolkata, India, seemed to carry only ctxB; thus these were El Tor variants or hybrids (no phenotypes were given to define the biotype)16. Similarity was found among the Thailand strains of this study, however, two years earlier than the Kolkata’s series. All of the Thai strains after 1992 carried ctxB of which 57 (19%) were hybrid biotype and 237 strains (81%) were El Tor variants according to the conventional biotyping method and MAMA- and conventional- PCR determinations. In Punjab and Haryana, northern India, where a re-emergence of classical V. cholerae has not been reported, the V. cholerae hybrid biotype were also found in 2007 (80% of the isolates)26. As has been mentioned earlier, many V. cholerae isolates of several other countries in Asia and Africa were also found to be biotype hybrid/El Tor variant15 indicating that the El Tor V. cholerae bacteria, regardless of the geographical areas, tend to evolve for acquisition of the classical CTX prophage. This phenomenon will have impact, more or less, on the treatment of cholera, public health measures, as well as vaccine development.
  20 in total

1.  Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage.

Authors:  Je Hee Lee; Kyung Ho Han; Seon Young Choi; Marcelino E S Lucas; C Mondlane; M Ansaruzzaman; G Balakrish Nair; David A Sack; Lorenz von Seidlein; John D Clemens; Manki Song; Jongsik Chun; Dong Wook Kim
Journal:  J Med Microbiol       Date:  2006-02       Impact factor: 2.472

2.  Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae.

Authors:  K J Bart; Z Huq; M Khan; W H Mosley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

Review 3.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Vibrio cholerae O139 Bengal in Bangkok.

Authors:  M Chongsa-nguan; W Chaicumpa; P Moolasart; P Kandhasingha; T Shimada; H Kurazono; Y Takeda
Journal:  Lancet       Date:  1993-08-14       Impact factor: 79.321

5.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

Authors:  T Ramamurthy; S Garg; R Sharma; S K Bhattacharya; G B Nair; T Shimada; T Takeda; T Karasawa; H Kurazano; A Pal
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  [Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin, and addition of novel serogroups].

Authors:  S Yamai; T Okitsu; T Shimada; Y Katsube
Journal:  Kansenshogaku Zasshi       Date:  1997-10

7.  New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.

Authors:  G Balakrish Nair; Shah M Faruque; N A Bhuiyan; M Kamruzzaman; A K Siddique; David A Sack
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 8.  Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae.

Authors:  S M Faruque; M J Albert; J J Mekalanos
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

Review 9.  Cholera.

Authors:  David A Sack; R Bradley Sack; G Balakrish Nair; A K Siddique
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

10.  Classical Vibrio cholerae biotype displaces EL tor in Bangladesh.

Authors:  A R Samadi; M I Huq; N Shahid; M U Khan; A Eusof; A S Rahman; M Yunus; A S Faruque
Journal:  Lancet       Date:  1983-04-09       Impact factor: 79.321

View more
  13 in total

1.  Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal.

Authors:  Geeta Shakya; Dong Wook Kim; John D Clemens; Sarala Malla; Bishnu Prasad Upadhyaya; Shyam Prakash Dumre; Sirjana Devi Shrestha; Shailaja Adhikari; Supriya Sharma; Nisha Rijal; Sanjaya K Shrestha; Carl Mason; Palpasa Kansakar
Journal:  World J Microbiol Biotechnol       Date:  2012-05-23       Impact factor: 3.312

2.  The seventh pandemic Vibrio cholerae O1 El Tor isolate in China has undergone genetic shifts.

Authors:  Ping Zhang; Fengjuan Li; Weili Liang; Jie Li; Biao Kan; Duochun Wang
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

3.  Drug response and genetic properties of Vibrio cholerae associated with endemic cholera in north-eastern Thailand, 2003-2011.

Authors:  Chariya Chomvarin; Fatema-Tuz Johura; Shahnewaj B Mannan; Warin Jumroenjit; Boonnapa Kanoktippornchai; Waraluk Tangkanakul; Napaporn Tantisuwichwong; Sriwanna Huttayananont; Haruo Watanabe; Nur A Hasan; Anwar Huq; Alejandro Cravioto; Rita R Colwell; Munirul Alam
Journal:  J Med Microbiol       Date:  2013-01-14       Impact factor: 2.472

4.  Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.

Authors:  Saravut Satitsri; Pawin Pongkorpsakol; Potjanee Srimanote; Varanuj Chatsudthipong; Chatchai Muanprasat
Journal:  Virulence       Date:  2016-05-24       Impact factor: 5.882

5.  Rapid spread of Vibrio cholerae O1 El Tor variant in Odisha, Eastern India, in 2008 and 2009.

Authors:  H K Khuntia; B B Pal; S K Samal; S K Kar
Journal:  J Clin Microbiol       Date:  2013-03-20       Impact factor: 5.948

6.  Zebrafish as a natural host model for Vibrio cholerae colonization and transmission.

Authors:  Donna L Runft; Kristie C Mitchell; Basel H Abuaita; Jonathan P Allen; Sarah Bajer; Kevin Ginsburg; Melody N Neely; Jeffrey H Withey
Journal:  Appl Environ Microbiol       Date:  2013-12-27       Impact factor: 4.792

7.  On the emergence of atypical Vibrio cholerae O1 El Tor & cholera epidemic.

Authors:  Ana Carolina Paulo Vicente
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

8.  Genotypic and PFGE/MLVA analyses of Vibrio cholerae O1: geographical spread and temporal changes during the 2007-2010 cholera outbreaks in Thailand.

Authors:  Kazuhisa Okada; Amonrattana Roobthaisong; Ichiro Nakagawa; Shigeyuki Hamada; Siriporn Chantaroj
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

9.  Hybrid Vibrio cholerae El Tor lacking SXT identified as the cause of a cholera outbreak in the Philippines.

Authors:  David C Klinzing; Seon Young Choi; Nur A Hasan; Ronald R Matias; Enrique Tayag; Josefina Geronimo; Evan Skowronski; Shah M Rashed; Kent Kawashima; C Nicole Rosenzweig; Henry S Gibbons; Brian C Torres; Veni Liles; Alicia C Alfon; Maria Luisa Juan; Filipinas F Natividad; Thomas A Cebula; Rita R Colwell
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

10.  Decades of cholera in Odisha, India (1993-2015): lessons learned and the ways forward.

Authors:  Hemant Kumar Khuntia; Thandavarayan Ramamurthy; Madhusmita Bal; Sanghamitra Pati; Manoranjan Ranjit
Journal:  Epidemiol Infect       Date:  2021-06-07       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.